Appeals Court Overturns FDA Approval Of Generic Paclitaxel, A Setback For Ivax.
Henderson Heads HHS Preparedness Office; NCI Awards $22M Southern Cohort Study.
Detroit’s “Dr. Vee” Honored For 50 Years In Medicine.
In Setback For Generics, Court Overturns FDA.
Advisors Suggest Consortia For Lung Cancer Research.
Young Elected ACS President, Von eschenback Pres.-Elect.
Trending Stories
- On Day 2 as director of NYU Perlmutter, Anirban Maitra talks about the advantages of running a matrix cancer center
- Spending bill passed by the House gives NIH $415M raise, NCI gets $128M
Legislation caps proportion of NIH grants to receive multiyear funding; indirect costs remain untouched - Letai: NCAB’s ad hoc working group plays major role in advising NCI on extramural research
The group replaced the NCI Board of Scientific Advisors - Supportive cancer care is the smart investment our leaders in Washington can’t afford to ignore
- Mail-out colorectal cancer screening programs extend, rather than replace, clinical care
- After a brief government shutdown, FY26 funding bill is signed into law
NIH gets $415M raise, NCI gets $128M more, CDMRP funding largely restored









